Clinical Trial Update: Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients [Phase 2]

View source ↗

Summary

Phase 2 trial in chronic kidney disease patients with secondary hyperparathyroidism completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, Chronic Renal Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2011-03-01